Reduced insulin secretion in normoglycaemic patients with β-thalassaemia major
Aims To assess insulin sensitivity and secretion in the fasting state in regularly transfused patients with β‐thalassaemia major with normal glucose response during an oral glucose tolerance test and to estimate its possible relation to iron overload. Methods We measured fasting glucose, insulin a...
Saved in:
Published in | Diabetic medicine Vol. 23; no. 12; pp. 1327 - 1331 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Blackwell Publishing Ltd
01.12.2006
Blackwell |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Aims To assess insulin sensitivity and secretion in the fasting state in regularly transfused patients with β‐thalassaemia major with normal glucose response during an oral glucose tolerance test and to estimate its possible relation to iron overload.
Methods We measured fasting glucose, insulin and C‐peptide levels in 24 patients with β‐thalassaemia major and 18 control subjects matched for age and body mass index. Insulin sensitivity and insulin release index were calculated according to the homeostasis model assessment (HOMA). Correlations with age, body mass index and serum ferritin were also calculated.
Results Fasting glucose levels in patients were increased compared with control subjects (5.5 ± 0.12 vs. 4.7 ± 0.13 mmol/l, mean ± sem, P < 0.001). Pancreatic B‐cell insulin secretion in the fasting state (estimated by SCHOMA) was lower in thalassaemic patients (SCHOMA 88.5 ± 11.11 vs. 184.3 ± 23.72 in control subjects, P < 0.001). Patients were then divided into those with impaired (IFG) and normal (NFG) fasting glucose. SCHOMA was higher in the patients with NFG compared with those with IFG patients (110.6 ± 17.63 vs. 66.3 ± 10.88, respectively, P < 0.05) but estimated insulin sensitivity (ISIHOMA) was similar. Plasma values of C‐peptide correlated positively with ferritin (r = 0.42, P = 0.04) and SCHOMA (r = 0.45, P = 0.02) and negatively with ISIHOMA (r = −0.43, P = 0.03).
Conclusions These results support the concept that impaired B‐cell function, as reflected by a reduction in the insulin secretion index, is present in β‐thalassaemic patients with normoglycaemia before changes in oral glucose tolerance tests are apparent. |
---|---|
AbstractList | Aims To assess insulin sensitivity and secretion in the fasting state in regularly transfused patients with β‐thalassaemia major with normal glucose response during an oral glucose tolerance test and to estimate its possible relation to iron overload.
Methods We measured fasting glucose, insulin and C‐peptide levels in 24 patients with β‐thalassaemia major and 18 control subjects matched for age and body mass index. Insulin sensitivity and insulin release index were calculated according to the homeostasis model assessment (HOMA). Correlations with age, body mass index and serum ferritin were also calculated.
Results Fasting glucose levels in patients were increased compared with control subjects (5.5 ± 0.12 vs. 4.7 ± 0.13 mmol/l, mean ± sem, P < 0.001). Pancreatic B‐cell insulin secretion in the fasting state (estimated by SCHOMA) was lower in thalassaemic patients (SCHOMA 88.5 ± 11.11 vs. 184.3 ± 23.72 in control subjects, P < 0.001). Patients were then divided into those with impaired (IFG) and normal (NFG) fasting glucose. SCHOMA was higher in the patients with NFG compared with those with IFG patients (110.6 ± 17.63 vs. 66.3 ± 10.88, respectively, P < 0.05) but estimated insulin sensitivity (ISIHOMA) was similar. Plasma values of C‐peptide correlated positively with ferritin (r = 0.42, P = 0.04) and SCHOMA (r = 0.45, P = 0.02) and negatively with ISIHOMA (r = −0.43, P = 0.03).
Conclusions These results support the concept that impaired B‐cell function, as reflected by a reduction in the insulin secretion index, is present in β‐thalassaemic patients with normoglycaemia before changes in oral glucose tolerance tests are apparent. To assess insulin sensitivity and secretion in the fasting state in regularly transfused patients with beta-thalassaemia major with normal glucose response during an oral glucose tolerance test and to estimate its possible relation to iron overload. We measured fasting glucose, insulin and C-peptide levels in 24 patients with beta-thalassaemia major and 18 control subjects matched for age and body mass index. Insulin sensitivity and insulin release index were calculated according to the homeostasis model assessment (HOMA). Correlations with age, body mass index and serum ferritin were also calculated. Fasting glucose levels in patients were increased compared with control subjects (5.5 +/- 0.12 vs. 4.7 +/- 0.13 mmol/l, mean +/- SEM, P < 0.001). Pancreatic B-cell insulin secretion in the fasting state (estimated by SC(HOMA)) was lower in thalassaemic patients (SC(HOMA) 88.5 +/- 11.11 vs. 184.3 +/- 23.72 in control subjects, P < 0.001). Patients were then divided into those with impaired (IFG) and normal (NFG) fasting glucose. SC(HOMA) was higher in the patients with NFG compared with those with IFG patients (110.6 +/- 17.63 vs. 66.3 +/- 10.88, respectively, P < 0.05) but estimated insulin sensitivity (ISI(HOMA)) was similar. Plasma values of C-peptide correlated positively with ferritin (r = 0.42, P = 0.04) and SC(HOMA) (r = 0.45, P = 0.02) and negatively with ISI(HOMA) (r = -0.43, P = 0.03). These results support the concept that impaired B-cell function, as reflected by a reduction in the insulin secretion index, is present in beta-thalassaemic patients with normoglycaemia before changes in oral glucose tolerance tests are apparent. Abstract Aims To assess insulin sensitivity and secretion in the fasting state in regularly transfused patients with β‐thalassaemia major with normal glucose response during an oral glucose tolerance test and to estimate its possible relation to iron overload. Methods We measured fasting glucose, insulin and C‐peptide levels in 24 patients with β‐thalassaemia major and 18 control subjects matched for age and body mass index. Insulin sensitivity and insulin release index were calculated according to the homeostasis model assessment (HOMA). Correlations with age, body mass index and serum ferritin were also calculated. Results Fasting glucose levels in patients were increased compared with control subjects (5.5 ± 0.12 vs. 4.7 ± 0.13 mmol/l, mean ± sem , P < 0.001). Pancreatic B‐cell insulin secretion in the fasting state (estimated by SC HOMA ) was lower in thalassaemic patients (SC HOMA 88.5 ± 11.11 vs. 184.3 ± 23.72 in control subjects, P < 0.001). Patients were then divided into those with impaired (IFG) and normal (NFG) fasting glucose. SC HOMA was higher in the patients with NFG compared with those with IFG patients (110.6 ± 17.63 vs. 66.3 ± 10.88, respectively, P < 0.05) but estimated insulin sensitivity (ISI HOMA ) was similar. Plasma values of C‐peptide correlated positively with ferritin ( r = 0.42, P = 0.04) and SC HOMA ( r = 0.45, P = 0.02) and negatively with ISI HOMA ( r = −0.43, P = 0.03). Conclusions These results support the concept that impaired B‐cell function, as reflected by a reduction in the insulin secretion index, is present in β‐thalassaemic patients with normoglycaemia before changes in oral glucose tolerance tests are apparent. AIMSTo assess insulin sensitivity and secretion in the fasting state in regularly transfused patients with beta-thalassaemia major with normal glucose response during an oral glucose tolerance test and to estimate its possible relation to iron overload.METHODSWe measured fasting glucose, insulin and C-peptide levels in 24 patients with beta-thalassaemia major and 18 control subjects matched for age and body mass index. Insulin sensitivity and insulin release index were calculated according to the homeostasis model assessment (HOMA). Correlations with age, body mass index and serum ferritin were also calculated.RESULTSFasting glucose levels in patients were increased compared with control subjects (5.5 +/- 0.12 vs. 4.7 +/- 0.13 mmol/l, mean +/- SEM, P < 0.001). Pancreatic B-cell insulin secretion in the fasting state (estimated by SC(HOMA)) was lower in thalassaemic patients (SC(HOMA) 88.5 +/- 11.11 vs. 184.3 +/- 23.72 in control subjects, P < 0.001). Patients were then divided into those with impaired (IFG) and normal (NFG) fasting glucose. SC(HOMA) was higher in the patients with NFG compared with those with IFG patients (110.6 +/- 17.63 vs. 66.3 +/- 10.88, respectively, P < 0.05) but estimated insulin sensitivity (ISI(HOMA)) was similar. Plasma values of C-peptide correlated positively with ferritin (r = 0.42, P = 0.04) and SC(HOMA) (r = 0.45, P = 0.02) and negatively with ISI(HOMA) (r = -0.43, P = 0.03).CONCLUSIONSThese results support the concept that impaired B-cell function, as reflected by a reduction in the insulin secretion index, is present in beta-thalassaemic patients with normoglycaemia before changes in oral glucose tolerance tests are apparent. |
Author | Livadas, S. Angelopoulos, N. G. Adamopoulos, I. Zervas, A. Giannopoulos, D. Tolis, G. Goula, A. |
Author_xml | – sequence: 1 givenname: N. G. surname: Angelopoulos fullname: Angelopoulos, N. G. organization: Endocrine Department, 'Hippokrateion' Hospital of Athens, Endocrine Unit, 'Ag. Sophia' Children's University Hospital, Athens, †Haematological Department, General Hospital of Kalamata, Kalamata, ‡Biochemical Department, General Hospital of Kalamata, Kalamata and §First Division, 'Ag. Sophia' Children's University Hospital, Athens, Greece – sequence: 2 givenname: A. surname: Zervas fullname: Zervas, A. organization: Endocrine Department, 'Hippokrateion' Hospital of Athens, Endocrine Unit, 'Ag. Sophia' Children's University Hospital, Athens, †Haematological Department, General Hospital of Kalamata, Kalamata, ‡Biochemical Department, General Hospital of Kalamata, Kalamata and §First Division, 'Ag. Sophia' Children's University Hospital, Athens, Greece – sequence: 3 givenname: S. surname: Livadas fullname: Livadas, S. organization: Endocrine Department, 'Hippokrateion' Hospital of Athens, Endocrine Unit, 'Ag. Sophia' Children's University Hospital, Athens, †Haematological Department, General Hospital of Kalamata, Kalamata, ‡Biochemical Department, General Hospital of Kalamata, Kalamata and §First Division, 'Ag. Sophia' Children's University Hospital, Athens, Greece – sequence: 4 givenname: I. surname: Adamopoulos fullname: Adamopoulos, I. organization: Endocrine Department, 'Hippokrateion' Hospital of Athens, Endocrine Unit, 'Ag. Sophia' Children's University Hospital, Athens, †Haematological Department, General Hospital of Kalamata, Kalamata, ‡Biochemical Department, General Hospital of Kalamata, Kalamata and §First Division, 'Ag. Sophia' Children's University Hospital, Athens, Greece – sequence: 5 givenname: D. surname: Giannopoulos fullname: Giannopoulos, D. organization: Endocrine Department, 'Hippokrateion' Hospital of Athens, Endocrine Unit, 'Ag. Sophia' Children's University Hospital, Athens, †Haematological Department, General Hospital of Kalamata, Kalamata, ‡Biochemical Department, General Hospital of Kalamata, Kalamata and §First Division, 'Ag. Sophia' Children's University Hospital, Athens, Greece – sequence: 6 givenname: A. surname: Goula fullname: Goula, A. organization: Endocrine Department, 'Hippokrateion' Hospital of Athens, Endocrine Unit, 'Ag. Sophia' Children's University Hospital, Athens, †Haematological Department, General Hospital of Kalamata, Kalamata, ‡Biochemical Department, General Hospital of Kalamata, Kalamata and §First Division, 'Ag. Sophia' Children's University Hospital, Athens, Greece – sequence: 7 givenname: G. surname: Tolis fullname: Tolis, G. organization: Endocrine Department, 'Hippokrateion' Hospital of Athens, Endocrine Unit, 'Ag. Sophia' Children's University Hospital, Athens, †Haematological Department, General Hospital of Kalamata, Kalamata, ‡Biochemical Department, General Hospital of Kalamata, Kalamata and §First Division, 'Ag. Sophia' Children's University Hospital, Athens, Greece |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18302929$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/17116183$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkMtO3DAUhi0EKsPAK1TZtLsEX5LYWXRRAWXQcFG5dWk5zknxNHGmdiJmXosH4ZlwOiPY9mx85PP9x9Z3gHZtZwGhiOCEhDpeJCTN0zhLC5JQjPMEk0KIZLWDJu-DXTTBPKUxw5zsowPvFxgTWrDiE9onnJCcCDZBN7dQDRqqyFg_NMZGHrSD3nQ23ES2c233u1lrBa3R0VL1Bmzvo2fTP0WvL3H_pBrl_ThVUasWnTtEe7VqPBxtzyl6-HF2fzKLL2_OL06-X8Y6ZZmIqwzXOeQlFZTgjJRUVbrivNJC4KKAwJSEqTLAQDFjOqdZXYq05AHmacXZFH3d7F267u8Avpet8RqaRlnoBi9zQbjgNA2g2IDadd47qOXSmVa5tSRYjjLlQo7O5OhMjjLlP5lyFaKft28MZQvVR3BrLwBftoDyWjW1U1Yb_8EJhmkRlE_Rtw33bBpY__cH5OnV2diFfLzJG9_D6j2v3B-Zc8Yz-ev6XPJTdvfzcTaXc_YGxr2hoA |
CODEN | DIMEEV |
CitedBy_id | crossref_primary_10_1016_j_ando_2008_12_007 crossref_primary_10_3390_ijms241612928 crossref_primary_10_1016_j_parkreldis_2018_02_036 crossref_primary_10_2337_dc20_0908 crossref_primary_10_1002_dmrr_773 crossref_primary_10_1080_03630269_2017_1295983 crossref_primary_10_1111_pedi_12793 crossref_primary_10_1002_ajh_22223 crossref_primary_10_1097_MPH_0000000000001043 crossref_primary_10_1152_ajpgi_00453_2012 crossref_primary_10_1507_endocrj_EJ19_0191 crossref_primary_10_3390_ijms242316749 crossref_primary_10_1016_j_hermed_2019_100324 crossref_primary_10_1007_BF03346551 crossref_primary_10_1096_fj_201801855R crossref_primary_10_1111_j_1365_2141_2009_07970_x crossref_primary_10_1080_03630260902817131 crossref_primary_10_1007_s13410_019_00789_0 crossref_primary_10_1111_j_1365_2141_2006_06203_x crossref_primary_10_1016_j_bbmt_2011_09_013 crossref_primary_10_3109_03630269_2014_999081 crossref_primary_10_3109_03630269_2013_862541 crossref_primary_10_1586_17474086_2016_1136209 crossref_primary_10_1016_j_phoj_2017_12_005 crossref_primary_10_4081_thal_2014_4871 crossref_primary_10_1053_j_seminhematol_2011_10_006 crossref_primary_10_1111_ijpo_12601 |
Cites_doi | 10.1016/0026-0495(95)90155-8 10.1007/s00431-002-1121-7 10.2337/diacare.23.3.295 10.2337/diacare.21.4.671 10.1016/0026-0495(77)90126-3 10.1056/NEJM198803313181303 10.1002/dmr.5610050805 10.1007/BF00280883 10.1111/j.1600-051X.1997.tb01209.x 10.1016/S0026-0495(96)90038-4 10.1007/978-1-4615-2910-1_10 10.1111/j.1399-543X.2004.00051.x 10.1007/s00774-005-0660-1 10.1210/jc.77.2.478 10.1016/j.fertnstert.2005.05.070 10.1136/adc.51.3.195 10.1159/000068572 10.1007/s00198-005-1920-6 10.1177/000456328302000203 10.1111/j.1365-2265.1987.tb01177.x |
ContentType | Journal Article |
Copyright | 2007 INIST-CNRS |
Copyright_xml | – notice: 2007 INIST-CNRS |
DBID | BSCLL IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1111/j.1464-5491.2006.01988.x |
DatabaseName | Istex Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE CrossRef MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Nursing |
EISSN | 1464-5491 |
EndPage | 1331 |
ExternalDocumentID | 10_1111_j_1464_5491_2006_01988_x 17116183 18302929 DME1988 ark_67375_WNG_7D3SQVHK_K |
Genre | article Journal Article |
GroupedDBID | --- .3N .GA .GJ .Y3 05W 0R~ 10A 1CY 1OB 1OC 29F 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 6PF 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAJUZ AANLZ AAONW AASGY AAVGM AAWTL AAXRX AAZKR ABCQN ABCUV ABCVL ABEML ABHUG ABIJN ABJNI ABLJU ABOCM ABPTK ABPVW ABQWH ABWRO ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACFBH ACGFO ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACXBN ACXME ACXQS ADAWD ADBBV ADBTR ADDAD ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFVGU AFZJQ AGJLS AHBTC AHMBA AIACR AIAGR AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BSCLL BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 DUUFO EBS EJD ESX EX3 F00 F01 F04 F5P FEDTE FUBAC G-S G.N GODZA H.X HF~ HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OVD P2P P2W P2X P2Z P4B P4D PQQKQ Q.N Q11 QB0 R.K ROL RWI RX1 SAMSI SUPJJ TEORI UB1 V8K V9Y W8V W99 WBKPD WH7 WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WVDHM WXI WXSBR XG1 XV2 YFH YUY ZA5 ZGI ZXP ZZTAW ~IA ~WT AITYG HGLYW OIG AAPBV AKALU IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c4358-d50f6e6b2821051b2adcd77dc88099e435b13abc43e2033c625fb84b705174d73 |
IEDL.DBID | DR2 |
ISSN | 0742-3071 |
IngestDate | Fri Aug 16 22:05:14 EDT 2024 Fri Aug 23 02:19:17 EDT 2024 Thu May 23 23:49:59 EDT 2024 Sun Oct 22 16:03:55 EDT 2023 Sat Aug 24 01:13:41 EDT 2024 Wed Jan 17 05:04:34 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Keywords | Endocrinopathy Human fasting glycaemia Hemoglobinopathy Pancreatic hormone Secretion Diabetes mellitus Homeostasis Tolerance Hemopathy Glucose Insulin Genetic disease Hemolytic anemia β-Thalassemia β-thalassaemia major Models glucose tolerance Fast Glycemia homeostasis model assessment |
Language | English |
License | CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4358-d50f6e6b2821051b2adcd77dc88099e435b13abc43e2033c625fb84b705174d73 |
Notes | istex:098F221578F2844CB162485207732D5AAD0B1DF8 ark:/67375/WNG-7D3SQVHK-K ArticleID:DME1988 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 17116183 |
PQID | 68178724 |
PQPubID | 23479 |
PageCount | 5 |
ParticipantIDs | proquest_miscellaneous_68178724 crossref_primary_10_1111_j_1464_5491_2006_01988_x pubmed_primary_17116183 pascalfrancis_primary_18302929 wiley_primary_10_1111_j_1464_5491_2006_01988_x_DME1988 istex_primary_ark_67375_WNG_7D3SQVHK_K |
PublicationCentury | 2000 |
PublicationDate | December 2006 |
PublicationDateYYYYMMDD | 2006-12-01 |
PublicationDate_xml | – month: 12 year: 2006 text: December 2006 |
PublicationDecade | 2000 |
PublicationPlace | Oxford, UK |
PublicationPlace_xml | – name: Oxford, UK – name: Oxford – name: England |
PublicationTitle | Diabetic medicine |
PublicationTitleAlternate | Diabet Med |
PublicationYear | 2006 |
Publisher | Blackwell Publishing Ltd Blackwell |
Publisher_xml | – name: Blackwell Publishing Ltd – name: Blackwell |
References | Holl RW, Buck C, Cario H, Wolf A, Thon A, Heinze E et al. Diagnosis of diabetes mellitus in cystic fibrosis and thalassaemia major. Diabetes Care 1998; 21: 671-672. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985; 28: 412-419. Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki-Jarvinen H, Van Haeften T et al. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 2000; 23: 295-301. Dandona P, Hussain M, Varghese Z, Politis D, Flynn DM, Hoffbrand AV. Insulin resistance and iron overload. Ann Clin Biochem 1983; 20: 77-79. Angelopoulos N, Goula A, Rombopoulos G, Kaltzidou V, Katounda E, Kaltsas D et al. Hypoparathyroidism in transfusion-dependent patients with β-thalassaemia. J Bone Miner Metab 2006; 24: 87-93. Cario H, Holl RW, Debatin KM, Kohne E. Insulin sensitivity and beta-cell secretion in thalassaemia major with secondary haemochromatosis: assessment by oral glucose tolerance test. Eur J Pediatr 2003; 162: 139-146. Angelopoulos NG, Goula AK, Papanikolaou G, Tolis G. Osteoporosis in HFE2 juvenile hemochromatosis. A case report and review of the literature. Osteoporos Int 2006; 17: 150-155. Monge L, Pinach S, Caramellino L, Bertero MT, Dall'omo A, Carta Q. The possible role of autoimmunity in the pathogenesis of diabetes in β-thalassaemia major. Diabetes Metab 2001; 27: 149-54. Verma RS, Babu A, eds. Human Chromosomes: Principles and Techniques, 2nd edn. New York: McGraw-Hill Inc., 1995. Cario H, Holl R, Debatin K, Kohne E. Disproportionately elevated fasting proinsulin levels in normoglycemic patients with thalassaemia major are correlated to the degree of iron overload. Horm Res 2003; 59: 73-78. Petrides AS, DeFronzo RA. Glucose metabolism in cirrhosis. A review with some perspectives for the future. Diabetes Metab Rev 1989; 5: 691-709. Saudek CD, Hemm RM, Peterson CM. Abnormal glucose tolerance in β-thalassaemia major. Metabolism 1977; 26: 43-52. Olefsky JM. Insulin resistance and the pathogenesis of non-insulin dependent diabetes mellitus: cellular and molecular mechanisms. Adv Exp Med Biol 1993; 334: 129-150. Angelopoulos NG, Goula A, Dimitriou E, Tolis G. Reversibility of hypogonadotropic hypogonadism in a patient with the juvenile form of hemochromatosis. Fertil Steril 2005; 84: 1744. Kattamis CA, Kattamis AC. Management of thalassaemia: growth and development, hormone substitution, vitamin supplementation, and vaccination. Semin Hematol 1995; 32: 269-279. WHO Study Group. Diabetes mellitus. WHO Tech Rep Series 1985; 727: 1-113. Hramiak IM, Finegood DT, Adams PC. Factors affecting glucose tolerance in hereditary hemochromatosis. Clin Invest Med 1997; 20: 110-118. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2005; 28: S37-S42. Livadas DP, Economou E, Sofroniadou K, Fotiadou-Pappa H, Van Melle GD, Temler E et al. A study of beta-cell function after glucagon stimulation in thalassaemia major treated by high transfusion programme. Clin Endocrinol 1987; 27: 485-490. Pappas S, Donohue SM, Denver AE, Mohamed-Ali V, Goubet S, Yudkin JS. Glucose intolerance in thalassaemia major is related to insulin resistance and hepatic dysfunction. Metabolism 1996; 45: 652-657. Khalifa AS, Salem M, Mounir E, El-Tawil MM, El-Sawy M, Abd Al-Aziz MM. Abnormal glucose tolerance in Egyptian beta-thalassemic patients: possible association with genotyping. Pediatr Diabetes 2004; 5: 126-132. Dmochowski K, Finegood DT, Francombe W, Tyler B, Zinman B. Factors determining glucose tolerance in patients with thalassaemia major. J Clin Endocrinol Metab 1993; 77: 478-483. Merkel PA, Simonson DC, Amiel SA, Plewe G, Sherwin RS, Pearson HA et al. Insulin resistance and hyperinsulinemia in patients with thalassaemia major treated by hypertransfusion. N Engl J Med 1988; 318: 809-814. Cavallo-Perin P, Pacini G, Cerutti F, Bessone A, Condo C, Sacchetti L et al. Insulin resistance and hyperinsulinemia in homozygous β-thalassaemia. Metabolism 1995; 44: 281-286. McIntosh N. Endocrinopathy in thalassaemia major. Arch Dis Child 1976; 51: 195-201. 1989; 5 1985; 28 1977; 26 1985; 727 2000; 23 1997; 20 2006; 17 1995; 32 2005; 84 2003; 59 1995 2004; 5 2001; 27 1998; 21 2005; 28 1976; 51 2006; 24 1993; 77 1995; 44 2003; 162 1983; 20 1993; 334 1988; 318 1996; 45 1987; 27 e_1_2_7_5_2 Monge L (e_1_2_7_10_2) 2001; 27 e_1_2_7_4_2 Verma RS (e_1_2_7_25_2) 1995 e_1_2_7_3_2 e_1_2_7_2_2 e_1_2_7_9_2 e_1_2_7_8_2 e_1_2_7_7_2 e_1_2_7_6_2 Hramiak IM (e_1_2_7_19_2) 1997; 20 e_1_2_7_18_2 e_1_2_7_17_2 e_1_2_7_16_2 e_1_2_7_15_2 e_1_2_7_14_2 e_1_2_7_13_2 e_1_2_7_12_2 e_1_2_7_26_2 e_1_2_7_24_2 e_1_2_7_23_2 e_1_2_7_22_2 WHO Study Group. (e_1_2_7_11_2) 1985; 727 e_1_2_7_20_2 Kattamis CA (e_1_2_7_21_2) 1995; 32 |
References_xml | – volume: 44 start-page: 281 year: 1995 end-page: 286 article-title: Insulin resistance and hyperinsulinemia in homozygous β‐thalassaemia publication-title: Metabolism – volume: 45 start-page: 652 year: 1996 end-page: 657 article-title: Glucose intolerance in thalassaemia major is related to insulin resistance and hepatic dysfunction publication-title: Metabolism – volume: 23 start-page: 295 year: 2000 end-page: 301 article-title: Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity publication-title: Diabetes Care – volume: 26 start-page: 43 year: 1977 end-page: 52 article-title: Abnormal glucose tolerance in β‐thalassaemia major publication-title: Metabolism – volume: 84 start-page: 1744 year: 2005 article-title: Reversibility of hypogonadotropic hypogonadism in a patient with the juvenile form of hemochromatosis publication-title: Fertil Steril – volume: 727 start-page: 1 year: 1985 end-page: 113 article-title: Diabetes mellitus publication-title: WHO Tech Rep Series – volume: 5 start-page: 126 year: 2004 end-page: 132 article-title: Abnormal glucose tolerance in Egyptian beta‐thalassemic patients: possible association with genotyping publication-title: Pediatr Diabetes – volume: 27 start-page: 485 year: 1987 end-page: 490 article-title: A study of beta‐cell function after glucagon stimulation in thalassaemia major treated by high transfusion programme publication-title: Clin Endocrinol – volume: 20 start-page: 77 year: 1983 end-page: 79 article-title: Insulin resistance and iron overload publication-title: Ann Clin Biochem – volume: 77 start-page: 478 year: 1993 end-page: 483 article-title: Factors determining glucose tolerance in patients with thalassaemia major publication-title: J Clin Endocrinol Metab – volume: 28 start-page: S37 year: 2005 end-page: S42 article-title: Diagnosis and classification of diabetes mellitus publication-title: Diabetes Care – volume: 51 start-page: 195 year: 1976 end-page: 201 article-title: Endocrinopathy in thalassaemia major publication-title: Arch Dis Child – volume: 334 start-page: 129 year: 1993 end-page: 150 article-title: Insulin resistance and the pathogenesis of non‐insulin dependent diabetes mellitus: cellular and molecular mechanisms publication-title: Adv Exp Med Biol – volume: 21 start-page: 671 year: 1998 end-page: 672 article-title: Diagnosis of diabetes mellitus in cystic fibrosis and thalassaemia major publication-title: Diabetes Care – volume: 59 start-page: 73 year: 2003 end-page: 78 article-title: Disproportionately elevated fasting proinsulin levels in normoglycemic patients with thalassaemia major are correlated to the degree of iron overload publication-title: Horm Res – volume: 24 start-page: 87 year: 2006 end-page: 93 article-title: Hypoparathyroidism in transfusion‐dependent patients with β‐thalassaemia publication-title: J Bone Miner Metab – volume: 5 start-page: 691 year: 1989 end-page: 709 article-title: Glucose metabolism in cirrhosis. A review with some perspectives for the future publication-title: Diabetes Metab Rev – volume: 20 start-page: 110 year: 1997 end-page: 118 article-title: Factors affecting glucose tolerance in hereditary hemochromatosis publication-title: Clin Invest Med – volume: 28 start-page: 412 year: 1985 end-page: 419 article-title: Homeostasis model assessment: insulin resistance and b‐cell function from fasting plasma glucose and insulin concentration in man publication-title: Diabetologia – year: 1995 – volume: 162 start-page: 139 year: 2003 end-page: 146 article-title: Insulin sensitivity and beta‐cell secretion in thalassaemia major with secondary haemochromatosis: assessment by oral glucose tolerance test publication-title: Eur J Pediatr – volume: 32 start-page: 269 year: 1995 end-page: 279 article-title: Management of thalassaemia: growth and development, hormone substitution, vitamin supplementation, and vaccination publication-title: Semin Hematol – volume: 17 start-page: 150 year: 2006 end-page: 155 article-title: Osteoporosis in HFE2 juvenile hemochromatosis. A case report and review of the literature publication-title: Osteoporos Int – volume: 318 start-page: 809 year: 1988 end-page: 814 article-title: Insulin resistance and hyperinsulinemia in patients with thalassaemia major treated by hypertransfusion publication-title: N Engl J Med – volume: 27 start-page: 149 year: 2001 end-page: 54 article-title: The possible role of autoimmunity in the pathogenesis of diabetes in β‐thalassaemia major publication-title: Diabetes Metab – volume: 20 start-page: 110 year: 1997 ident: e_1_2_7_19_2 article-title: Factors affecting glucose tolerance in hereditary hemochromatosis publication-title: Clin Invest Med contributor: fullname: Hramiak IM – volume: 27 start-page: 149 year: 2001 ident: e_1_2_7_10_2 article-title: The possible role of autoimmunity in the pathogenesis of diabetes in β‐thalassaemia major publication-title: Diabetes Metab contributor: fullname: Monge L – ident: e_1_2_7_5_2 doi: 10.1016/0026-0495(95)90155-8 – ident: e_1_2_7_17_2 doi: 10.1007/s00431-002-1121-7 – ident: e_1_2_7_14_2 doi: 10.2337/diacare.23.3.295 – ident: e_1_2_7_12_2 doi: 10.2337/diacare.21.4.671 – volume-title: Human Chromosomes: Principles and Techniques year: 1995 ident: e_1_2_7_25_2 contributor: fullname: Verma RS – ident: e_1_2_7_3_2 doi: 10.1016/0026-0495(77)90126-3 – ident: e_1_2_7_7_2 doi: 10.1056/NEJM198803313181303 – ident: e_1_2_7_8_2 doi: 10.1002/dmr.5610050805 – ident: e_1_2_7_13_2 doi: 10.1007/BF00280883 – ident: e_1_2_7_15_2 doi: 10.1111/j.1600-051X.1997.tb01209.x – ident: e_1_2_7_4_2 doi: 10.1016/S0026-0495(96)90038-4 – ident: e_1_2_7_9_2 doi: 10.1007/978-1-4615-2910-1_10 – volume: 32 start-page: 269 year: 1995 ident: e_1_2_7_21_2 article-title: Management of thalassaemia: growth and development, hormone substitution, vitamin supplementation, and vaccination publication-title: Semin Hematol contributor: fullname: Kattamis CA – ident: e_1_2_7_26_2 doi: 10.1111/j.1399-543X.2004.00051.x – ident: e_1_2_7_16_2 doi: 10.1007/s00774-005-0660-1 – ident: e_1_2_7_6_2 doi: 10.1210/jc.77.2.478 – ident: e_1_2_7_22_2 doi: 10.1016/j.fertnstert.2005.05.070 – ident: e_1_2_7_2_2 doi: 10.1136/adc.51.3.195 – ident: e_1_2_7_18_2 doi: 10.1159/000068572 – ident: e_1_2_7_23_2 doi: 10.1007/s00198-005-1920-6 – volume: 727 start-page: 1 year: 1985 ident: e_1_2_7_11_2 article-title: Diabetes mellitus publication-title: WHO Tech Rep Series contributor: fullname: WHO Study Group. – ident: e_1_2_7_20_2 doi: 10.1177/000456328302000203 – ident: e_1_2_7_24_2 doi: 10.1111/j.1365-2265.1987.tb01177.x |
SSID | ssj0012939 |
Score | 2.0639892 |
Snippet | Aims To assess insulin sensitivity and secretion in the fasting state in regularly transfused patients with β‐thalassaemia major with normal glucose response... To assess insulin sensitivity and secretion in the fasting state in regularly transfused patients with beta-thalassaemia major with normal glucose response... Abstract Aims To assess insulin sensitivity and secretion in the fasting state in regularly transfused patients with β‐thalassaemia major with normal glucose... AIMSTo assess insulin sensitivity and secretion in the fasting state in regularly transfused patients with beta-thalassaemia major with normal glucose response... |
SourceID | proquest crossref pubmed pascalfrancis wiley istex |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 1327 |
SubjectTerms | Adult Anemias. Hemoglobinopathies beta-Thalassemia - blood beta-Thalassemia - complications Biological and medical sciences Blood Glucose - metabolism C-Peptide - metabolism Case-Control Studies Diabetes Mellitus - blood Diabetes Mellitus - etiology Diabetes Mellitus - metabolism Diabetes. Impaired glucose tolerance Diseases of red blood cells Endocrine pancreas. Apud cells (diseases) Endocrinopathies Etiopathogenesis. Screening. Investigations. Target tissue resistance fasting glycaemia Female glucose tolerance Glucose Tolerance Test Hematologic and hematopoietic diseases Homeostasis homeostasis model assessment Humans Insulin - deficiency Insulin - metabolism Insulin Secretion Male Medical sciences Models, Biological β-thalassaemia major |
Title | Reduced insulin secretion in normoglycaemic patients with β-thalassaemia major |
URI | https://api.istex.fr/ark:/67375/WNG-7D3SQVHK-K/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1464-5491.2006.01988.x https://www.ncbi.nlm.nih.gov/pubmed/17116183 https://search.proquest.com/docview/68178724 |
Volume | 23 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtQwEB6hIhCXAgXa8FN8QNyyimNvnBwRbVlRbaUWCr1ZduyAupBFm12p7YlH4Fl4EB6CJ2Em8W6VqgeEuEWJnZ_xjP3NePINwIvKIKZQlFFTVDKWRZrHuXRJXKS-4qIsPK8o3jE-yEbH8u3J8CTkP9G_MB0_xCrgRpbRztdk4MY2V41cxujf8LCngP5zPiA8Sbx6hI-OVkxStKoVHSNnSuEW3k_qufZGvZXqJgn9jDInTYPCq7qqF9fB0j7KbZepvbswWX5gl50yGSzmdlBeXOF-_D8SuAfrAc2yV5363Ycbvt6A2-OwX78Bt0Iw4gEcHhFHrHcsJL-zhvAqaQWeYTUi5-mnL-eloVx9FsheG0ZRYvbr5-_vP-af6YfPhq4b9tWcTmcP4Xhv9_3rURzKOcQlYrI8dsOkynxm0clDUMdtalzplHIlTiFF4bGN5cJYbOzTRIgSPbPK5tKqlk3bKfEI1upp7beAWZtwlxWG-6GQxjqrjMidswRubSZcBHw5dPpbx9qhe96O1CQ1qsGZ6VZq-iyCl-0YrzqY2YSy3tRQfzx4o9WOeHf4YbSv9yPY7inB5ROISw3hZgTPl1qh0VhpB8bUfrpodJZznCBTGcFmpyyXfRWn0gUigqwd8r9-bb0z3qWjx__a8QncSUMxpoQ_hbX5bOGfIdCa2-3WhP4Ao4sZzw |
link.rule.ids | 315,786,790,1382,27957,27958,46329,46753 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB6hVjwuPMorPFofELes4th5HRFtWdjuSi0t9GbZsQOiJYs2u1LhxE_gt_BD-BH8EmYS71apekCIW5TYeYxn7G_Gk28AnlUaMUVGGTVFJUNZxHmYSxuFRewqLsrC8YriHeNJOjySb46TY18OiP6F6fghVgE3sox2viYDp4D0RSuXITo43G8qoAOdDxBQrqP1J61_dbDikqJ1reg4OWMKuPB-Ws-ld-qtVesk9jPKndQNiq_q6l5cBkz7OLddqHZvwenyE7v8lJPBYm4G5bcL7I__SQa34aYHtOxFp4F34IqrN-Da2G_Zb8BVH4-4C_sHRBPrLPP576whyEqKgWdYjeB5-uH0a6kpXZ95vteGUaCY_fr5-_uP-Uf657Oh65p91p-ms3twtLtz-HIY-ooOYYmwLA9tElWpSw36eYjruIm1LW2W2RJnkaJw2MZwoQ02dnEkRInOWWVyabKWUNtm4j6s1dPaPQRmTMRtWmjuEiG1sSbTIrfWEL41qbAB8OXYqS8dcYfqOTxSkdSoDGeqWqmpswCet4O86qBnJ5T4liXq_eSVyrbF2_13w5EaBbDZ04LzJxCdGiLOALaWaqHQXmkTRtduumhUmnOcI2MZwINOW877ZpyqF4gA0nbM__q11fZ4h44e_WvHLbg-PBzvqb3Xk9FjuBH72kwRfwJr89nCPUXcNTebrT39AVbsHfE |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtQwEB6hVlRc-ClQUkqbA-KWVRx77eSI2C4Ly65oodCbZccOiKXZarMrFU59hD5LH4SH4EnwJN6tUvWAELcosfMznrG_GU--AXheKIcpBGbUZAWLWJakUcpMHGWJLQjNM0sKjHeMxnxwxN4ed499_hP-C9PwQ6wCbmgZ9XyNBn5qiutGziLn3xC_p-D857Tj8OQ64zRBDe8drqikcFnLGkrOBOMtpJ3Vc-OdWkvVOkr9DFMnVeWkVzRlL27CpW2YW69T_XswWX5hk54y6SzmupP_vEb--H9EcB_uejgbvmz07wHcsuUmbIz8hv0m3PbRiIdwcIgksdaEPvs9rBCwolq4M2HpoPP0y_cfucJk_dCzvVYhhonDX5e_zy_mX_GPzwqvq_BEfZvOHsFRf__jq0Hk6zlEuQNlaWS6ccEt187Lc6iO6ESZ3AhhcjeHZJl1bTShSrvGNokpzZ1rVuiUaVHTaRtBH8NaOS3tEwi1jonhmSK2S5nSRgtFU2M0olvNqQmALIdOnja0HbLl7jCJUsMinFzWUpNnAbyox3jVQc0mmPYmuvLz-LUUPfrh4NNgKIcB7LaU4OoJSKbm8GYAe0utkM5acQtGlXa6qCRPiZshExbAVqMsV30FwdoFNABeD_lfv7bsjfbxaPtfO-7BxvteX757Mx4-hTuJL8wUkx1Ym88W9pkDXXO9W1vTH9k1HKA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Reduced+insulin+secretion+in+normoglycaemic+patients+with+%CE%B2-thalassaemia+major&rft.jtitle=Diabetic+medicine&rft.au=ANGELOPOULOS%2C+N.+G&rft.au=ZERVAS%2C+A&rft.au=LIVADAS%2C+S&rft.au=ADAMOPOULOS%2C+I&rft.date=2006-12-01&rft.pub=Blackwell&rft.issn=0742-3071&rft.eissn=1464-5491&rft.volume=23&rft.issue=12&rft.spage=1327&rft.epage=1331&rft_id=info:doi/10.1111%2Fj.1464-5491.2006.01988.x&rft.externalDBID=n%2Fa&rft.externalDocID=18302929 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0742-3071&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0742-3071&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0742-3071&client=summon |